Loading...
Comparative evaluation of the new FDA approved THxID™-BRAF test with high resolution melting and sanger sequencing
BACKGROUND: Since patients diagnosed with BRAF V600E and V600K mutated advanced melanoma show response to treatment with MAP kinase inhibitors, several sensitive methods have been developed to determine the V600 allele status of melanoma patients. Vemurafenib (Zelboraf) and dabrafenib (Tafinlar) are...
Na minha lista:
| Udgivet i: | BMC Cancer |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4223712/ https://ncbi.nlm.nih.gov/pubmed/25037456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-519 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|